Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
03:057.
MicroRNA (miRNA)
03:528.
Circular RNA (CircRNA)
03:569.
MicroRNA (miRNA)
04:2110.
Circular RNA (CircRNA)
05:0011.
Functions of circRNA
05:3812.
PI3K/AKT pathway
07:0413.
The expression and prognostic significance of circWAC in TNBC
15:5114.
Features of circWAC
32:2815.
CircWAC was mainly distributed in the cytoplasm
37:5616.
CircWAC decrease chemosensitivity to PTX in TNBC
37:5717.
CircWAC was mainly distributed in the cytoplasm
38:1518.
CircWAC decrease chemosensitivity to PTX in TNBC
38:1819.
CircWAC was mainly distributed in the cytoplasm
39:2020.
CircWAC decrease chemosensitivity to PTX in TNBC
44:1521.
CircWAC decrease chemosensitivity to PTX in TNBC
45:3122.
CircWAC decrease chemosensitivity to PTX in TNBC
54:1423.
CircWAC acts as a sponge of miR-142 in TNBC
54:1524.
CircWAC decrease chemosensitivity to PTX in TNBC
55:3625.
CircWAC acts as a sponge of miR-142 in TNBC
56:4126.
CircWAC acts as a sponge of miR-142 in TNBC
56:4427.
CircWAC acts as a sponge of miR-142 in TNBC
57:1428.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2329.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2430.
CircWAC acts as a sponge of miR-142 in TNBC
1:11:2631.
CircWAC acts as a sponge of miR-142 in TNBC
1:13:3432.
CircWAC regulates PTX resistance by targeting miR-142
1:19:5433.
CircWAC regulates PTX resistance by targeting miR-142
1:21:1334.
WWP1 is the direct target gene of miR-142
1:25:2035.
WWP1 is the direct target gene of miR-142
1:25:5536.
WWP1 is the direct target gene of miR-142
1:29:5537.
The expression and prognostic significance of circWAC in TNBC
1:30:4138.
Inhibition of circWAC increases sensitivity to PTX in vivo
1:39:5839.
Conclusion
1:43:2640.
Inhibition of circWAC increases sensitivity to PTX in vivo
6. Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
7. MicroRNA (miRNA)
8. Circular RNA (CircRNA)
9. MicroRNA (miRNA)
10. Circular RNA (CircRNA)
11. Functions of circRNA
12. PI3K/AKT pathway
13. The expression and prognostic significance of circWAC in TNBC
14. Features of circWAC
15. CircWAC was mainly distributed in the cytoplasm
16. CircWAC decrease chemosensitivity to PTX in TNBC
17. CircWAC was mainly distributed in the cytoplasm
18. CircWAC decrease chemosensitivity to PTX in TNBC
19. CircWAC was mainly distributed in the cytoplasm
20. CircWAC decrease chemosensitivity to PTX in TNBC
21. CircWAC decrease chemosensitivity to PTX in TNBC
22. CircWAC decrease chemosensitivity to PTX in TNBC
23. CircWAC acts as a sponge of miR-142 in TNBC
24. CircWAC decrease chemosensitivity to PTX in TNBC
25. CircWAC acts as a sponge of miR-142 in TNBC
26. CircWAC acts as a sponge of miR-142 in TNBC
27. CircWAC acts as a sponge of miR-142 in TNBC
28. CircWAC acts as a sponge of miR-142 in TNBC
29. CircWAC acts as a sponge of miR-142 in TNBC
30. CircWAC acts as a sponge of miR-142 in TNBC
31. CircWAC acts as a sponge of miR-142 in TNBC
32. CircWAC regulates PTX resistance by targeting miR-142
33. CircWAC regulates PTX resistance by targeting miR-142
34. WWP1 is the direct target gene of miR-142
35. WWP1 is the direct target gene of miR-142
36. WWP1 is the direct target gene of miR-142
37. The expression and prognostic significance of circWAC in TNBC
38. Inhibition of circWAC increases sensitivity to PTX in vivo
39. Conclusion
40. Inhibition of circWAC increases sensitivity to PTX in vivo
1/40
速度 :
畫質 :
1024 x 768
Volume
00:00/1:46:50
00:00/00:02
寫筆記
loading ...
00:001.
index 1
00:022.
Slide 1
00:303.
index 2
00:584.
Breast Cancer
01:405.
Triple-Negative Breast Cancer(TNBC)
02:266.
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
03:057.
MicroRNA (miRNA)
03:528.
Circular RNA (CircRNA)
03:569.
MicroRNA (miRNA)
04:2110.
Circular RNA (CircRNA)
05:0011.
Functions of circRNA
05:3812.
PI3K/AKT pathway
07:0413.
The expression and prognostic significance of circWAC in TNBC
15:5114.
Features of circWAC
32:2815.
CircWAC was mainly distributed in the cytoplasm
37:5616.
CircWAC decrease chemosensitivity to PTX in TNBC
37:5717.
CircWAC was mainly distributed in the cytoplasm
38:1518.
CircWAC decrease chemosensitivity to PTX in TNBC
38:1819.
CircWAC was mainly distributed in the cytoplasm
39:2020.
CircWAC decrease chemosensitivity to PTX in TNBC
44:1521.
CircWAC decrease chemosensitivity to PTX in TNBC
45:3122.
CircWAC decrease chemosensitivity to PTX in TNBC
54:1423.
CircWAC acts as a sponge of miR-142 in TNBC
54:1524.
CircWAC decrease chemosensitivity to PTX in TNBC
55:3625.
CircWAC acts as a sponge of miR-142 in TNBC
56:4126.
CircWAC acts as a sponge of miR-142 in TNBC
56:4427.
CircWAC acts as a sponge of miR-142 in TNBC
57:1428.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2329.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2430.
CircWAC acts as a sponge of miR-142 in TNBC
1:11:2631.
CircWAC acts as a sponge of miR-142 in TNBC
1:13:3432.
CircWAC regulates PTX resistance by targeting miR-142
1:19:5433.
CircWAC regulates PTX resistance by targeting miR-142
1:21:1334.
WWP1 is the direct target gene of miR-142
1:25:2035.
WWP1 is the direct target gene of miR-142
1:25:5536.
WWP1 is the direct target gene of miR-142
1:29:5537.
The expression and prognostic significance of circWAC in TNBC
1:30:4138.
Inhibition of circWAC increases sensitivity to PTX in vivo
1:39:5839.
Conclusion
1:43:2640.
Inhibition of circWAC increases sensitivity to PTX in vivo
Paclitaxel(PTX) is frequently used as the first-line treatment drug in BC.Chemoresistance is a major problem of cancer treatment associated with poor response.Mechanism of action of PTX
03:057.
MicroRNA (miRNA)
03:528.
Circular RNA (CircRNA)
03:569.
MicroRNA (miRNA)
04:2110.
Circular RNA (CircRNA)
05:0011.
Functions of circRNA
05:3812.
PI3K/AKT pathway
07:0413.
The expression and prognostic significance of circWAC in TNBC
15:5114.
Features of circWAC
32:2815.
CircWAC was mainly distributed in the cytoplasm
37:5616.
CircWAC decrease chemosensitivity to PTX in TNBC
37:5717.
CircWAC was mainly distributed in the cytoplasm
38:1518.
CircWAC decrease chemosensitivity to PTX in TNBC
38:1819.
CircWAC was mainly distributed in the cytoplasm
39:2020.
CircWAC decrease chemosensitivity to PTX in TNBC
44:1521.
CircWAC decrease chemosensitivity to PTX in TNBC
45:3122.
CircWAC decrease chemosensitivity to PTX in TNBC
54:1423.
CircWAC acts as a sponge of miR-142 in TNBC
54:1524.
CircWAC decrease chemosensitivity to PTX in TNBC
55:3625.
CircWAC acts as a sponge of miR-142 in TNBC
56:4126.
CircWAC acts as a sponge of miR-142 in TNBC
56:4427.
CircWAC acts as a sponge of miR-142 in TNBC
57:1428.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2329.
CircWAC acts as a sponge of miR-142 in TNBC
1:01:2430.
CircWAC acts as a sponge of miR-142 in TNBC
1:11:2631.
CircWAC acts as a sponge of miR-142 in TNBC
1:13:3432.
CircWAC regulates PTX resistance by targeting miR-142
1:19:5433.
CircWAC regulates PTX resistance by targeting miR-142
1:21:1334.
WWP1 is the direct target gene of miR-142
1:25:2035.
WWP1 is the direct target gene of miR-142
1:25:5536.
WWP1 is the direct target gene of miR-142
1:29:5537.
The expression and prognostic significance of circWAC in TNBC
1:30:4138.
Inhibition of circWAC increases sensitivity to PTX in vivo
1:39:5839.
Conclusion
1:43:2640.
Inhibition of circWAC increases sensitivity to PTX in vivo